<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02609646</url>
  </required_header>
  <id_info>
    <org_study_id>AbioKin</org_study_id>
    <nct_id>NCT02609646</nct_id>
  </id_info>
  <brief_title>AbioKin - Antibiotic Kinetics</brief_title>
  <official_title>Antibiotic Pharmacokinetics in Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the pharmacokinetic properties in critically ill&#xD;
      patients of a few of the most used antimicrobial drugs (amikacin, linezolid, meropenem,&#xD;
      piperacillin/tazobactam, vancomycin). The primary objective is the identification of the&#xD;
      clinical parameters affecting the kinetics of these drugs and the study of the contribution&#xD;
      of extracorporeal depuration techniques to the elimination of these molecules. The secondary&#xD;
      objective is to describe and compare the therapeutic therapies adopted in the Intensive Care&#xD;
      Units participating in the project.&#xD;
&#xD;
      For each molecule, the study will involve 300 patients admitted to Intensive Care Units. For&#xD;
      each patient five blood samples will be collected on average, in order to measure drug plasma&#xD;
      concentrations. Patient clinical conditions will be collected through an electronic clinical&#xD;
      record. Finally, on the basis of those data, pharmacokinetic models will be developed to&#xD;
      describe the evolution in time of drug plasma concentrations.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2016</start_date>
  <completion_date type="Actual">June 26, 2020</completion_date>
  <primary_completion_date type="Actual">June 26, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Drug plasma concentration (time-dependent antibiotics)</measure>
    <time_frame>30 min after first dose; 1 day after first dose; 2 day after first dose; 2 measures between the 3rd and the 8th day of treatment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Drug plasma concentration (concentration-dependent antibiotics)</measure>
    <time_frame>30 min after first dose; immediately before second dose; peak and trough of the same dose in the 2nd day of therapy; peak and trough of the same dose between the 3rd and the 5th day of therapy</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">1500</enrollment>
  <condition>Critical Illness</condition>
  <condition>Infection</condition>
  <arm_group>
    <arm_group_label>linezolid</arm_group_label>
    <description>patients treated with linezolid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>meropenem</arm_group_label>
    <description>patients treated with meropenem</description>
  </arm_group>
  <arm_group>
    <arm_group_label>piperacillin/tazobactam</arm_group_label>
    <description>patients treated with piperacillin/tazobactam</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vancomycin</arm_group_label>
    <description>patients treated with vancomycin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Linezolid</intervention_name>
    <description>Drug choice is performed according to standard clinical practice, that will not be modified by the participation in the study. As a consequence, assignment of patients to groups is not protocol based, but it is defined by standard clinical choices.</description>
    <arm_group_label>linezolid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Meropenem</intervention_name>
    <description>Drug choice is performed according to standard clinical practice, that will not be modified by the participation in the study. As a consequence, assignment of patients to groups is not protocol based, but it is defined by standard clinical choices.</description>
    <arm_group_label>meropenem</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Piperacillin-tazobactam combination product</intervention_name>
    <description>Drug choice is performed according to standard clinical practice, that will not be modified by the participation in the study. As a consequence, assignment of patients to groups is not protocol based, but it is defined by standard clinical choices.</description>
    <arm_group_label>piperacillin/tazobactam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vancomycin</intervention_name>
    <description>Drug choice is performed according to standard clinical practice, that will not be modified by the participation in the study. As a consequence, assignment of patients to groups is not protocol based, but it is defined by standard clinical choices.</description>
    <arm_group_label>vancomycin</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples to measure antibiotic plasma concentration&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to Intensive Care Unit (ICU)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients undergoing antibiotic therapy with amikacin, linezolid, meropenem,&#xD;
             piperacillin/tazobactam, or vancomycin.&#xD;
&#xD;
          -  patients whose antibiotic therapy started during the stay in ICU or less than 24h&#xD;
             before admission to ICU.&#xD;
&#xD;
          -  patients with anticipated length of stay in ICU of at least 24h.&#xD;
&#xD;
          -  patients with already-placed catheter&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients undergoing antibiotic prophylaxis&#xD;
&#xD;
          -  lack of informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefano Finazzi, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mario Negri Institute for Pharmacological Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elena Garbero, M.Sci</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mario Negri Institute for Pharmacological Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ospedale Maurizio Bufalini, UO Anestesia Terapia Intensiva</name>
      <address>
        <city>Cesena</city>
        <state>Emilia Romagna</state>
        <zip>47023</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Giovanni di Dio ASL 10, Servizio Anestesia e Rianimazione</name>
      <address>
        <city>Firenze</city>
        <state>FI</state>
        <zip>50143</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale San Giovanni di Dio</name>
      <address>
        <city>Orbetello</city>
        <state>Grosseto</state>
        <zip>58016</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Presidio Ospedaliero &quot;San Leopoldo Mandic&quot;</name>
      <address>
        <city>Merate</city>
        <state>Lecco</state>
        <zip>23807</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale A. Manzoni, U.O. Anestesia e Rianimazione 1</name>
      <address>
        <city>Lecco</city>
        <state>Lombardia</state>
        <zip>23900</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale San Giovanni Bosco, Servizio Anestesia e Rianimazione B-DEA</name>
      <address>
        <city>Torino</city>
        <state>Piemonte</state>
        <zip>10148</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Policlinico San Matteo</name>
      <address>
        <city>Pavia</city>
        <state>PV</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale del Mugello</name>
      <address>
        <city>Borgo San Lorenzo</city>
        <state>Toscana</state>
        <zip>50032</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Santa Maria Nuova, Anestesia e Rianimazione</name>
      <address>
        <city>Firenze</city>
        <state>Toscana</state>
        <zip>50122</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Maggiore, C.A. Pizzardi</name>
      <address>
        <city>Bologna</city>
        <zip>40133</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Misericordia</name>
      <address>
        <city>Grosseto</city>
        <zip>58016</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <study_first_submitted>November 18, 2015</study_first_submitted>
  <study_first_submitted_qc>November 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2015</study_first_posted>
  <last_update_submitted>January 15, 2021</last_update_submitted>
  <last_update_submitted_qc>January 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anti-Infective Agents</keyword>
  <keyword>Pharmacokinetics</keyword>
  <keyword>Critically ill patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vancomycin</mesh_term>
    <mesh_term>Meropenem</mesh_term>
    <mesh_term>Tazobactam</mesh_term>
    <mesh_term>Linezolid</mesh_term>
    <mesh_term>Piperacillin</mesh_term>
    <mesh_term>Piperacillin, Tazobactam Drug Combination</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

